Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Colorcon
Medtronic
McKinsey
Boehringer Ingelheim
Baxter

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for N,N-Dimethyltryptamine

See Plans and Pricing

« Back to Dashboard

What is the drug development status for N,N-Dimethyltryptamine?

N,N-Dimethyltryptamine is an investigational drug.

There have been 5 clinical trials for N,N-Dimethyltryptamine. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2009.

The most common disease conditions in clinical trials are Tobacco Use Disorder, Depression, and [disabled in preview]. The leading clinical trial sponsors are Heffter Research Institute, Johns Hopkins University, and New York University.

Recent Clinical Trials for N,N-Dimethyltryptamine
TitleSponsorPhase
Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS SurvivorsHeffter Research InstitutePhase 1
Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS SurvivorsRiver Styx FoundationPhase 1
Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS SurvivorsStupski FoundationPhase 1

See all N,N-Dimethyltryptamine clinical trials

Clinical Trial Summary for N,N-Dimethyltryptamine

Top disease conditions for N,N-Dimethyltryptamine
Top clinical trial sponsors for N,N-Dimethyltryptamine

See all N,N-Dimethyltryptamine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Mallinckrodt
McKinsey
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.